These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid. Tamayo J, Orden B, Cacho J, Cuadros J, Gomez-Garces JL, Alos JI. Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031 [Abstract] [Full Text] [Related]
3. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011. Bouchillon SK, Badal RE, Hoban DJ, Hawser SP. Clin Ther; 2013 Jun; 35(6):872-7. PubMed ID: 23623624 [Abstract] [Full Text] [Related]
5. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E. Acta Med Croatica; 2004 Jun; 58(4):307-12. PubMed ID: 15700687 [Abstract] [Full Text] [Related]
6. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Morosini MI, García-Castillo M, Coque TM, Valverde A, Novais A, Loza E, Baquero F, Cantón R. Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760 [Abstract] [Full Text] [Related]
7. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. Tängdén T, Adler M, Cars O, Sandegren L, Löwdin E. J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794 [Abstract] [Full Text] [Related]
8. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India. Behera B, Mathur P, Das A, Kapil A. Singapore Med J; 2009 Jun; 50(6):628-32. PubMed ID: 19551319 [Abstract] [Full Text] [Related]
9. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals. Fraenkel CJ, Ullberg M, Bernander S, Ericson E, Larsson P, Rydberg J, Törnqvist E, Melhus A. Scand J Infect Dis; 2006 Jun; 38(10):853-9. PubMed ID: 17008228 [Abstract] [Full Text] [Related]
19. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study. Cuevas O, Cercenado E, Gimeno M, Marín M, Coronel P, Bouza E, Spanish Urinary Tract Infection Study Group (SUTIS). Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206 [Abstract] [Full Text] [Related]